The Rheumatologist
COVID-19 NewsACR Convergence
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Gout Resource Center
      • Axial Spondyloarthritis Resource Center
      • Psoriatic Arthritis
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Kentucky Launches Probe into Drug Overcharges by Pharmacy Benefit Managers

Kentucky Launches Probe into Drug Overcharges by Pharmacy Benefit Managers

March 25, 2019 • By Reuters Staff

  • Tweet
  • Email
Print-Friendly Version / Save PDF

(Reuters)—Kentucky Attorney General Andy Beshear said on Thursday he had launched an investigation into allegations that pharmacy benefit managers (PBMs) had overcharged state health insurance programs for drugs and discriminated against independent pharmacies.

You Might Also Like
  • U.S. Probes Contracts Between Drugmakers, Pharmacy Benefit Managers
  • Ohio Accuses UnitedHealth’s OptumRx of Drug Overcharges
  • Rheumatologists Air Frustrations with Pharmacy Benefit Managers at Annual Meeting
Also By This Author
  • U.S. Official Says 8.8 Million People Signed Up for 2018 Obamacare Health Plans

The investigation comes against the backdrop of widespread criticism of rising costs of prescription medicines in the United States, with PBMs, middlemen who negotiate prices for employers and health insurers, coming under intense scrutiny.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Ohio’s attorney general earlier this week sued UnitedHealth Group’s OptumRx unit, which houses the largest U.S. health insurer’s PBM business, to recover nearly $16 million in prescription drug overcharges. The lawsuit followed a probe that began under Governor Mike DeWine before he left his position of attorney general earlier this year.

Beshear said in a statement that he was seeking details on how PBMs have determined, billed and paid drug reimbursement rates over the past five years in Kentucky.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

“PBMs were originally established to help companies and government programs better manage pharmacy costs, but have grown into powerful industry middlemen that go to great lengths to hide and complicate drug pricing information,” Beshear said.

A report released last month by the state indicated that two PBMs took in $123.5 million last year from the state Medicaid program by paying pharmacies a lower rate to fill prescriptions, while charging the state more for the same drugs, Beshear said.

Over 1.5 million Kentuckians receive pharmacy benefits through Medicaid and the state employee health plan’s PBMs, and thousands more receive pharmacy benefits through PBMs retained by private insurance plans, according to estimates.

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

 

Filed Under: Legal, Pharma Co. News Tagged With: Kentucky PBM probe, pharmacy benefit managers (PBMs), rising U.S. drug costs

You Might Also Like:
  • U.S. Probes Contracts Between Drugmakers, Pharmacy Benefit Managers
  • Ohio Accuses UnitedHealth’s OptumRx of Drug Overcharges
  • Rheumatologists Air Frustrations with Pharmacy Benefit Managers at Annual Meeting
  • Kentucky Accuses McKesson of Helping Fuel the Opioid Epidemic

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use / Cookie Preferences

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2023 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)